Lifitegrast, Bezlotoxumab, and Sugammadex sodium. [electronic resource]
Producer: 20190213Description: 284-287 p. digitalISSN:- 1544-3450
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Neutralizing -- therapeutic use
- Broadly Neutralizing Antibodies
- Clostridium Infections -- drug therapy
- Dry Eye Syndromes -- drug therapy
- Humans
- Neuromuscular Agents -- therapeutic use
- Ophthalmic Solutions -- therapeutic use
- Phenylalanine -- analogs & derivatives
- Practice Guidelines as Topic
- Sugammadex -- therapeutic use
- Sulfones -- therapeutic use
No physical items for this record
Publication Type: Letter; Review
There are no comments on this title.
Log in to your account to post a comment.